Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection
about
The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosisAn essential nonredundant role for mycobacterial DnaK in native protein foldingMycobacterium tuberculosis RsdA provides a conformational rationale for selective regulation of -factor activity by proteolysisStructural and functional insights into caseinolytic proteases reveal an unprecedented regulation principle of their catalytic triadStructural Basis of Mycobacterial Inhibition by Cyclomarin ALassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2Mycobacterium tuberculosis Hip1 modulates macrophage responses through proteolysis of GroEL2Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome.Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome.Enhanced specialized transduction using recombineering in Mycobacterium tuberculosisCloning and characterization of Clp protease proteolytic subunit 2 and its implication in clinical diagnosis of tuberculosisA bacterial toxin inhibits DNA replication elongation through a direct interaction with the β sliding clamp.Crystal structure of Mycobacterium tuberculosis ClpP1P2 suggests a model for peptidase activation by AAA+ partner binding and substrate delivery.The C-terminus of ClpC1 of Mycobacterium tuberculosis is crucial for its oligomerization and functionThe ClpP protease is required for the stress tolerance and biofilm formation in Actinobacillus pleuropneumoniae.Substrate specificity of MarP, a periplasmic protease required for resistance to acid and oxidative stress in Mycobacterium tuberculosis.Regulated Expression Systems for Mycobacteria and Their ApplicationsMycobacterium tuberculosis ClpP proteases are co-transcribed but exhibit different substrate specificities.The Mycobacterium tuberculosis Clp gene regulator is required for in vitro reactivation from hypoxia-induced dormancy.Protein-coding housekeeping gene Rv2461c can be used as an amplification target in loop-mediated isothermal amplification assay for the detection of Mycobacterium tuberculosis in sputum samplesThe cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo.Post-translational regulation via Clp protease is critical for survival of Mycobacterium tuberculosis.Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity.The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteriaAttenuated Actinobacillus pleuropneumoniae double-deletion mutant S-8∆clpP/apxIIC confers protection against homologous or heterologous strain challenge.Mycobacterium tuberculosis ESAT-6 exhibits a unique membrane-interacting activity that is not found in its ortholog from non-pathogenic Mycobacterium smegmatis.Integration-dependent bacteriophage immunity provides insights into the evolution of genetic switches.Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis.The Protease Locus of Francisella tularensis LVS Is Required for Stress Tolerance and Infection in the Mammalian Host.Chromosomal rearrangements and protein globularity changes in Mycobacterium tuberculosis isolates from cerebrospinal fluid.Mycobacterial Caseinolytic Protease Gene Regulator ClgR Is a Substrate of Caseinolytic Protease.Virulence factors of the Mycobacterium tuberculosis complexProteases in Mycobacterium tuberculosis pathogenesis: potential as drug targets.Genomic tools to profile antibiotic mode of action.Recently disclosed chemical entities as potential candidates for management of tuberculosis.Mechanistic insights into bacterial AAA+ proteases and protein-remodelling machines.Acyldepsipeptide antibiotics as a potential therapeutic agent against Clostridium difficile recurrent infections.Mycobacterium tuberculosis Prolyl Oligopeptidase Induces In vitro Secretion of Proinflammatory Cytokines by Peritoneal Macrophages.Development of new antituberculosis drugs from natural products.
P2860
Q26795478-272C8C56-3E93-414D-895D-05B6CBF63F3CQ27314706-F8BCDB07-EDBE-40CD-9263-23593E422567Q27675886-70361A02-774B-4530-A0E2-58878DF42447Q27678774-1BED7AD7-4102-4A92-B67A-0C7EED7ACA01Q27679912-7501D655-8085-4DDC-BABF-9B7A5DCF580DQ27682707-1BFF7879-63F8-4C0D-A31A-FC16F0AE83EBQ28538895-B9788F9F-190D-45AA-B4C7-402CD3820D39Q33601825-939FA51D-5558-4263-8672-6489D67CCD68Q33607221-802EA62C-1302-408F-A3F7-8A1B81389B61Q33709564-B9DA08AE-067B-4CC2-934C-0A6B0BFD841AQ34371280-8A30DC24-BCBA-4F63-BA77-556B3E92F5D3Q34385523-584011F6-0200-46CC-B32F-FE603BB99D70Q34442361-6D356C04-47BB-48E4-A05C-BAF3F141760BQ34531740-F503D3C5-E839-4FFF-8A51-24C368CB34E7Q34551568-F454B73B-3E57-4005-9C1F-34927A2A58CBQ34624840-3CFA38D3-3253-4AA1-B256-CC13DF399BDEQ34626585-B5E28046-F031-4255-8C15-8F42ED6A1C7FQ34656348-3B8A4CED-2BE2-4F31-AE22-F63947380DDEQ35002980-F474011D-21AC-4E1A-B7B9-DA71369816DCQ35038408-243518F6-3DBF-4C3A-8F3C-33BD6B98C624Q35106042-39B0C171-DA2E-4750-AE43-BF56F98BC333Q35113287-1F8C992A-1393-46E6-BB25-D39A88B6A984Q35536311-07E03C12-5E32-4FDC-925B-7E018D0176CAQ35620145-247A7DB7-297F-4E6F-96FD-0BE07EED167DQ35620201-EAC5E81D-6AE9-4EC1-9E7A-CE9AE0C0E04CQ36243182-B017D60D-CF7A-49CF-82C7-D4D3F87BAD05Q36492775-51D74488-7799-4DB4-8609-67493B85ACEFQ36569233-EF535936-03E3-42DA-A1C1-643FAC64B089Q36755029-1070B5BA-B38B-40EE-9614-54BABF6A6F6AQ36888447-21088B0D-A848-4F28-BBCA-6CF27F1FAE9DQ37282173-3CCCF1B1-6E6B-4842-9281-2FB163C8F08FQ37703346-98D37AA3-00E9-4D01-90FF-82454FE962AAQ38053069-143D9581-0D8A-4D86-92C9-EA7D5E497556Q38103940-63580D15-2346-4B5A-AB5E-2D3977019A6CQ38195069-0E6A3015-C3D9-4934-BAB8-224C451D2852Q38547127-340F3876-8DCA-420C-BBBC-E2ABF33AF94DQ38660358-7BA2F3E0-E4F7-44FA-9BAF-1B88DFBFFEACQ38829284-B21C13BC-0B2B-4066-A1DE-22AB8352EEDFQ38949083-5B693AEC-6304-4172-BA47-347A7CF8E618Q39019430-67326E56-F54D-4919-9BC4-464926124263
P2860
Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Mycobacterium tuberculosis Clp ...... in vitro and during infection
@ast
Mycobacterium tuberculosis Clp ...... in vitro and during infection
@en
Mycobacterium tuberculosis Clp ...... in vitro and during infection
@nl
type
label
Mycobacterium tuberculosis Clp ...... in vitro and during infection
@ast
Mycobacterium tuberculosis Clp ...... in vitro and during infection
@en
Mycobacterium tuberculosis Clp ...... in vitro and during infection
@nl
prefLabel
Mycobacterium tuberculosis Clp ...... in vitro and during infection
@ast
Mycobacterium tuberculosis Clp ...... in vitro and during infection
@en
Mycobacterium tuberculosis Clp ...... in vitro and during infection
@nl
P2093
P2860
P3181
P1433
P1476
Mycobacterium tuberculosis Clp ...... in vitro and during infection
@en
P2093
Alfred L Goldberg
Daniel H F Rubin
Eric J Rubin
Olga Kandror
Ravikiran M Raju
Tatos N Akopian
Vidhya Krishnamoorthy
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1002511
P407
P577
2012-02-16T00:00:00Z